Merck Loses HHS Suit Over Medicare Drug Price Program
By Jared Foretek · August 24, 2026, 7:10 PM EDT
A D.C. federal judge shot down Merck's challenge to the Inflation Reduction Act's Drug Price Negotiation Program on Monday, ruling that the pharmaceutical giant's voluntary participation in connected Medicare and Medicaid...
To view the full article, register now.